Onto Innovation

ONTO · NYSE

$219.62−$6.66 (−2.94%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $226.28

ONTO analyst rating

BuyConsensus of 13 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy13
Hold0
Underperform0
Sell0

12-month price target · 14 analysts

Average $392.31 (+78.6% upside)

Low: $333.30
Now: $219.62
High: $472.50

Upgrades and downgrades

The latest rating actions, newest first

ONTO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Oct 2, 2026	Initiates	Outperform	$400.00	69%
Morgan Stanley	Sep 8, 2026	Maintains	Overweight	$383.00 → $360.00	50%
Goldman Sachs	Aug 17, 2026	Initiates	Buy	$400.00	54%
Needham	Aug 7, 2026	Maintains	Buy	$330.00 → $360.00	58%
Evercore ISI Group	Aug 7, 2026	Maintains	Outperform	$350.00 → $390.00	61%
Jefferies	Aug 7, 2026	Maintains	Buy	$350.00 → $400.00	60%
Cantor Fitzgerald	Jun 29, 2026	Maintains	Overweight	$350.00 → $410.00	58%
Oppenheimer	Jun 22, 2026	Maintains	Outperform	$370.00 → $450.00	47%
Freedom Broker	Jun 17, 2026	Initiates	Buy	$370.00	0%
Deutsche Bank	Jun 5, 2026	Initiates	Buy	$350.00	46%

The case for and against

Updated Oct 14, 2026

Bull case

Onto Innovation is supported by strong secular demand in semiconductor process control, as GenAI-driven WFE growth, rising HBM/CoWoS intensity, and the shift to gate-all-around logic expand the need for higher-precision inspection and metrology. Its Dragonfly and Atlas platforms are core differentiators, with advanced packaging revenue on track to grow 80% this year, advanced nodes expected to grow about 35% in 2026, and backlog and customer adoption providing unusual visibility into 2027. Financially, gross margin improved to 57.0% in 2Q26 and operating margin recovered to 30.0%, while a net-cash balance sheet, recurring software and services revenue, and limited China exposure strengthen the company’s resilience and upside.

Bear case

Onto Innovation is challenged by a highly cyclical business model, with a beta of 2.4 and revenue and margins that are very sensitive to demand swings, leaving the stock prone to amplified volatility and sharp drawdowns. Although China exposure is only about 4% in F2Q26 and management expects it to stay near current levels in 2026 and beyond, the larger risk is weakening advanced packaging spending, delayed panel-level packaging and silicon photonics adoption until 2028 and 2030, and growing competition from KLA and ASML. Semilab adds only about $90-100 million of annualized revenue versus a cyclical headwind in 2026 from weaker EV demand, while concentrated customer exposure to TSMC, Samsung, and Intel leaves earnings vulnerable to any capex cuts or fab-space constraints.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.